This page contains a Flash digital edition of a book.
Doctor of Medicine (MD)


Director of Studies: Dr Paul McKean. Duration: 24 months full-time. Entry Requirements: Applicants must (i) hold a medical or dental qualification which is recognised by the General Medical/Dental Council for the United Kingdom, (ii) must have held this qualification for at least three years by the date of submission, and (iii) must be employed during their period of registration in appropriate clinical or scientific work in hospitals or institutions associated with the university, within the local NHS region. Assessment: Original research and thesis. IELTS: 6.5 Funding: See page 213. Further Information: www.lancs.ac.uk/shm/bls/


The Doctor of Medicine Degree scheme provides opportunities for clinically qualified candidates to undertake a two-year (Doctoral Level) research project at Lancaster. Our links with the Division of Medicine at Lancaster, Liverpool Medical School and many NHS trusts provide a wide range of opportunities for medically-related research. Candidates are supervised by both an academic member of staff in Biomedical and Life Sciences, or Medicine, and a clinical supervisor.


RESEARCH AREAS Research within Biomedical and Life Sciences focuses on the study of molecular and cellular aspects of human health and disease, using a range of biochemical and cellular approaches to complement studies in model organisms.


Key areas of research include the molecular pathology of neurodegenerative disease, fundamental mechanisms underlying carcinogenesis, molecular microbiology and medical cell biology.


Neurodegenerative Disease Progressive degeneration of the nervous system is a feature of a number of human diseases characterised by impaired movement or cognition. Researchers in the Division are studying the underlying processes that lead to brain dysfunction and degeneration in conditions such as Alzheimer’s disease, Parkinson’s disease and hydrocephalus.


106 School of Health and Medicine


Professor David Allsop, Dr Fiona Benson, Dr Ed Parkin and Dr Jane Owen-Lynch.


Prof Allsop has a long-standing interest in Alzheimer’s disease, particularly studying unusual protein deposits that accumulate in the brain. One aim of his research is to develop methods to enable early diagnosis of Alzheimer’s disease. Prof Allsop and Dr Benson are also studying the mechanisms of protein aggregation and cytotoxicity, processes that are fundamental to understanding disease progression in Parkinson’s disease and motor neuron disease. The aim of these studies is to develop methods to prevent protein aggregation which may alleviate symptoms of these devastating diseases. Dr Parkin’s interest in Alzheimer’s disease specifically lies in the role of copper and the proteolytic processing of amyloid precursor protein in relation to disease pathogenesis. Dr Owen-Lynch’s interests are at the other end of the age spectrum looking at disorders of brain development, for example hydrocephalus, focusing on the role of cerebrospinal fluid in normal and abnormal development of the cortex.


Cancer Biology Research groups at Lancaster are investigating a number of different aspects of the molecular and cellular biology of cancer including: cellular effects of exposure to carcinogens and ultraviolet light, DNA repair mechanisms, cell cycle control, and the molecular events behind leukaemia.


Professor Trevor McMillan, Dr Jane Owen-Lynch, Dr Howard Lindsay, Dr Fiona Benson, Dr Sarah Allinson, Dr Rachael Rigby, Dr Sue Broughton, Dr Karen Wright, Dr Ed Parkin and Dr Clive Price.


Staff are engaged in various aspects of cancer research, including carcinogenesis induced by UV, ionising radiation and chemicals, and the molecular mechanisms of leukaemogenesis. Dr Benson and Dr Allinson’s research is focused on studying the fundamental mechanisms of homologous recombination and base excision repair employed by human cells for repairing DNA damage, pathways essential for maintaining genome stability. Dr Price and Dr Lindsay study cell cycle control in model organisms such as yeast and Xenopus cell free egg extracts. One focus of this research is to gain a greater


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196  |  Page 197  |  Page 198  |  Page 199  |  Page 200  |  Page 201  |  Page 202  |  Page 203  |  Page 204  |  Page 205  |  Page 206  |  Page 207  |  Page 208  |  Page 209  |  Page 210  |  Page 211  |  Page 212  |  Page 213  |  Page 214  |  Page 215  |  Page 216  |  Page 217  |  Page 218  |  Page 219  |  Page 220  |  Page 221  |  Page 222  |  Page 223  |  Page 224  |  Page 225  |  Page 226  |  Page 227  |  Page 228
Produced with Yudu - www.yudu.com